Do we need screening for microalbuminuria in Type 2 diabetes?

被引：0
|
作者：
Seereiner, S
Rakovac, I
Habacher, W
Beck, P
Gfrerer, R
Pieber, TR
机构：
[1] Graz Univ, Dept Internal Med, Graz, Austria
[2] Joanneum Res, Graz, Austria
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
955
引用
收藏
页码：A309 / A309
页数：1
相关论文
共 50 条
  • [1] Prevention of Microalbuminuria in Patients With Type 2 Diabetes: What Do We Know?
    Ruilope, Luis
    Izzo, Joseph
    Haller, Hermann
    Waeber, Bernard
    Oparil, Suzanne
    Weber, Michael
    Bakris, George
    Sowers, James
    JOURNAL OF CLINICAL HYPERTENSION, 2010, 12 (06): : 422 - 430
  • [2] Do we need new treatments for type 2 diabetes?
    Gomez-Peralta, Fernando
    Abreu Padin, Cristina
    ENDOCRINOLOGIA Y NUTRICION, 2014, 61 (06): : 323 - 328
  • [3] Dapagliflozin - do we need it registered for type 2 diabetes?
    Doggrell, Sheila A.
    Tuli, Rinku
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1631 - 1635
  • [4] Microalbuminuria: do we need a new threshold?
    Zamora, C. R.
    Cubeddu, L. X.
    JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (02) : 146 - 149
  • [5] Microalbuminuria: do we need a new threshold?
    C R Zamora
    L X Cubeddu
    Journal of Human Hypertension, 2009, 23 : 146 - 149
  • [6] Pioglitazone - Do we really need it to manage type 2 diabetes?
    Sinha, Binayak
    Ghosal, Samit
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (04) : 243 - 246
  • [7] Polyneuropathy in type 1 and type 2 diabetes: do we need different examinations?
    Gdynia, Hans-Juergen
    Ludolph, Albert C.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (02) : 107 - 108
  • [8] Pioglitazone-Do we really need it to manage type 2 diabetes?
    Sinha, Binayak
    Ghosal, Samit
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (01) : 52 - 55
  • [9] Do We Need Another Guideline on Managing Type 2 Diabetes in India?
    Gangadhar, Prathosh
    Palikhe, Gaurav
    CLINICAL DIABETOLOGY, 2023, 12 (01): : 4 - 5
  • [10] Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?
    Jabbour, Serge
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (18) : 2751 - 2752
12345